• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Biogen Idec

Biogen Idec

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Research and Markets: Global Glomerulonephritis Pipeline Report 2015 - 12 Companies & 13 Drug Profiles

    Research and Markets: Global Glomerulonephritis Pipeline Report 2015 - 12 Companies & 13 Drug Profiles

  2. Research and Markets: Global Ischemic Stroke Pipeline Report 2015

    Research and Markets: Global Ischemic Stroke Pipeline Report 2015

  3. Biogen Announces $5 Billion Share Repurchase Program

    Biogen Announces $5 Billion Share Repurchase Program

  4. UPDATE: 5 charts that show stock buybacks are rapidly losing their luster

    UPDATE: 5 charts that show stock buybacks are rapidly losing their luster

  5. Ignyta Announces First Quarter 2015 Company Highlights and Financial Results

    Ignyta Announces First Quarter 2015 Company Highlights and Financial Results

  6. Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO

    Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO

  7. Biotech Boom, or Bubble?

    All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. The information provided in this posting is not a complete analysis of every material fact regarding any country, region, ...

  8. Announcing the Morningstar Fund Managers of the Year for 2014

    Success starts with teamwork for this year's winners.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.